Why this quality standard is needed
Peripheral arterial disease (PAD) is a condition in which the arteries that carry blood to the limbs are narrowed or blocked by a build-up of fatty deposits (called atheroma).
The most common initial symptom of PAD is leg pain (usually in the calf) while walking. This is known as intermittent claudication. In most people with intermittent claudication, the symptoms remain stable. Approximately 10-20% of people may develop increasingly severe symptoms and 5-10% may develop critical limb ischaemia. Critical limb ischaemia is characterised by severely diminished circulation, ischaemic pain at rest and tissue loss (ulceration and/or gangrene). Overall, approximately 1-2% of people with intermittent claudication will eventually undergo lower limb amputation, although the risk is higher (about 5%) in people with diabetes.
The incidence of PAD increases with age, and about 20% of people over 60 years have some form of PAD. Smoking is the most important risk factor for PAD; other risk factors include diabetes, high cholesterol and high blood pressure.
PAD is also a marker for an increased risk (3-4 fold) of other cardiovascular morbidity and mortality (heart attack and ischaemic stroke), even if it is asymptomatic. Symptomatic PAD significantly impairs quality of life through reduced mobility, severe pain and tissue loss (ulceration and/or gangrene). It is the largest single cause of lower limb amputation in the UK.
How this quality standard supports delivery of outcome frameworks
NICE quality standards are a concise set of prioritised statements designed to drive measureable quality improvements within a particular area of health or care. They are derived from high-quality 
Coordinated services
The quality standard for PAD specifies that services should be commissioned from and coordinated across all relevant agencies encompassing the whole PAD care pathway. A person-centred, integrated approach to providing services is fundamental to delivering high-quality care to people with PAD.
The Health and Social Care Act 2012 sets out a clear expectation that the care system should consider NICE quality standards in planning and delivering services, as part of a general duty to secure continuous improvement in quality. Commissioners and providers of health and social care
should refer to the library of NICE quality standards when designing high-quality services. Other quality standards that should also be considered when choosing, commissioning or providing a high-quality PAD service are listed in Related quality standards.
T Tr raining and competencies aining and competencies
The quality standard should be read in the context of national and local guidelines on training and competencies. All health and social care practitioners involved in assessing, caring for and treating people with PAD should have sufficient and appropriate training and competencies to deliver the Peripheral arterial disease (QS52)
actions and interventions described in the quality standard.
Role of families and carers Role of families and carers
Quality standards recognise the important role families and carers have in supporting people with PAD. If appropriate, health and social care practitioners should ensure that family members and carers are involved in the decision-making process about investigations, treatment and care.
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List of quality statements List of quality statements confirmed it is appropriate, after advice on the benefits of modifying risk factors has been given and after a supervised exercise programme has not improved symptoms.
Quality statement 1: Identification and assessment of peripher Quality statement 1: Identification and assessment of peripheral arterial al arterial disease disease
Quality statement
People who have symptoms of, or who are at risk of developing, peripheral arterial disease (PAD) are offered a clinical assessment and ankle brachial pressure index (ABPI) measurement.
Rationale
Early identification of both asymptomatic and symptomatic PAD means that treatment can begin earlier, potentially slowing disease progression and improving quality of life through better mobility and reduced pain. Early identification and treatment of PAD and its risk factors may also reduce the risk of cardiovascular morbidity and mortality, and the need for lower limb amputation. A comprehensive assessment should include both a clinical assessment with structured history taking, and ABPI measurement with a hand-held doppler ultrasound scan to ensure an accurate diagnosis and quantification of disease severity.
Quality measures
Structure Structure 
What the quality statement means for service providers, health and social care practitioners, and commissioners
Service pro Service providers viders ensure that hand-held doppler ultrasounds are adequately available; that staff are trained to recognise the symptoms of PAD; and that people who have symptoms of PAD or who are at risk of developing it are offered a clinical assessment and ABPI measurement.
Health and social care pr Health and social care practitioners actitioners ensure that they are aware of the symptoms of PAD and the need to have these symptoms assessed; that they are aware of the risk factors for PAD; and that healthcare practitioners ensure that they offer a clinical assessment and ABPI measurement to people who have symptoms of PAD or who are at risk of developing it.
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Commissioners Commissioners ensure that they commission services that have an adequate supply of hand-held doppler ultrasounds, and have staff trained to carry out clinical assessments and ABPI measurements in people who have symptoms of PAD or who are at risk of developing it.
What the quality statement means for patients, service users and carers P People with possible peripher eople with possible peripheral arterial disease, and people who are at risk of de al arterial disease, and people who are at risk of dev veloping eloping peripher peripheral arterial disease al arterial disease receive a thorough assessment to find out whether or not they have it, in which they are asked about their symptoms, their legs and feet are examined, their pulses are checked, and the blood pressures in their arms and ankles are compared.
Source guidance
Lower limb peripheral arterial disease (NICE clinical guideline 147), recommendations 1.3.1 and 1.3.2 (key priorities for implementation).
Definitions of terms used in this quality statement
Symptoms of P Symptoms of PAD AD include:
non-healing wounds on the legs or feet unexplained leg pain pain in the leg when walking that resolves when stopping (intermittent claudication), pain in the foot at rest, often made worse by elevation (for example, in bed at night disturbing sleep and relieved by hanging the foot down) tissue loss (ulceration and/or gangrene).
[ 
Rationale
People with both asymptomatic and symptomatic PAD have an increased risk of mortality from cardiovascular disease, mainly due to heart attack and stroke. It is therefore important to assess people with PAD for other cardiovascular comorbidities and modifiable risk factors, so that appropriate evidence-based treatment, advice and support can be given to reduce this risk.
Quality measures
Structure Structure
Evidence of local arrangements to ensure that people with PAD are offered an assessment of cardiovascular comorbidities and modifiable risk factors.
Data sour
Data source: ce: Local data collection.
Process Process
Proportion of people with PAD who receive an assessment of cardiovascular comorbidities and modifiable risk factors.
Numerator -the number of people in the denominator receiving an assessment of cardiovascular comorbidities and modifiable risk factors.
Denominator -the number of people with PAD. 
Data sour
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Service pro Service providers viders ensure that staff are trained to carry out assessments for cardiovascular comorbidities and modifiable risk factors.
Healthcare pr Healthcare practitioners actitioners ensure that they offer people with PAD an assessment for cardiovascular comorbidities and modifiable risk factors.
Commissioners Commissioners ensure that they commission services so that staff are trained on how to assess for cardiovascular comorbidities and modifiable risk factors.
What the quality statement means for patients, service users and carers
P People with peripher eople with peripheral arterial disease al arterial disease are offered an assessment to check their risk of having a heart attack or a stroke, and identify any lifestyle factors that they can alter to reduce their risk (for example, eating healthily, reducing alcohol consumption, stopping smoking, maintaining a healthy weight and exercising regularly).
Source guidance
Lower limb peripheral arterial disease (NICE clinical guideline 147), recommendation 1.2.1 (key priority for implementation). 
Definitions of terms used in this quality statement
Quality statement
People with intermittent claudication are offered a supervised exercise programme.
Rationale
Supervised exercise programmes can improve walking distance and quality of life for people with intermittent claudication. However, the provision of services varies across the country and so there is a need for both new provision and improvement in existing care.
Quality measures
Structure Structure
Evidence of local arrangements to ensure the availability of supervised exercise programmes. Numerator -the number of people in the denominator offered a supervised exercise programme.
Data sour
Denominator -the number of people with intermittent claudication. Numerator -the number of people in the denominator starting a supervised exercise programme.
Denominator -the number of people with intermittent claudication offered a supervised exercise programme. 
What the quality statement means for service providers, healthcare practitioners and commissioners
Service pro Service providers viders ensure the availability of a supervised exercise programme for all people with intermittent claudication.
Healthcare pr Healthcare practitioners actitioners ensure that they offer supervised exercise programmes to all people with intermittent claudication.
Commissioners Commissioners ensure that they commission supervised exercise programmes that can be offered to all people with intermittent claudication.
What the quality statement means for patients, service users and carers
P People who ha eople who hav ve pain when walking because of poor circulation e pain when walking because of poor circulation are offered a supervised exercise
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Quality statement 4: Imaging Quality statement 4: Imaging
Quality statement
People with peripheral arterial disease (PAD) being considered for revascularisation who need further imaging after a duplex ultrasound are offered magnetic resonance angiography (MRA).
Rationale
Imaging should only be performed in people with PAD if it is likely to provide information that will influence their management. Duplex ultrasound followed by MRA, where clinically appropriate and if needed, offers the most accurate, safe and cost-effective imaging strategy for people with PAD.
However, local training and expertise and the availability of imaging equipment may be variable.
Quality measures
Process Process
Proportion of people with PAD being considered for revascularisation needing further imaging after a duplex ultrasound who receive MRA.
Numerator -the number of people in the denominator receiving MRA.
Denominator -the number of people with PAD being considered for revascularisation who need further imaging after a duplex ultrasound.
Data sour Data source: ce: Local data collection. Contained within NICE clinical guideline 147 audit support -
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imaging and supervised exercise programmes: audit standard 2.
What the quality statement means for service providers, healthcare practitioners and commissioners
Service pro Service providers viders ensure that imaging equipment is adequately available, and that people with PAD who are being considered for revascularisation and need further imaging after a duplex ultrasound are offered MRA.
Healthcare pr Healthcare practitioners actitioners ensure that they offer MRA to people with PAD who are being considered for revascularisation who need further imaging after a duplex ultrasound imaging.
Commissioners Commissioners ensure that they commission services with adequate availability of imaging equipment and which offer MRA to people with PAD being considered for revascularisation who need further imaging after a duplex ultrasound.
What the quality statement means for patients, service users and carers
P People with peripher eople with peripheral arterial disease al arterial disease whose healthcare practitioner thinks surgery might help to improve their blood flow, are offered imaging tests (for example, an ultrasound) to see whether surgery would be suitable.
Source guidance
Lower limb peripheral arterial disease (NICE clinical guideline 147), recommendations 1.4.1, 1.4.2 (key priority for implementation) and 1.4.3.
Definitions of terms used in this quality statement
Re Revascularisation vascularisation is any procedure that is used to restore blood flow to an area of the body that is supplied by narrowed or blocked arteries. This can be done either by making the narrowed arteries wider (angioplasty, stenting), or by using another blood vessel to bypass the blocked or narrowed artery (bypass surgery).
[Adapted from information for the public for NICE clinical guideline 147] P People being considered for re eople being considered for revascularisation include those: vascularisation include those:
with intermittent claudication, who should be offered angioplasty only when:
advice on the benefits of modifying risk factors has been reinforced (see recommendation 1.2.1) and and a supervised exercise programme has not led to a satisfactory improvement in symptoms and and imaging has confirmed that angioplasty is suitable for the person being considered for primary stent placement, for treating people with intermittent claudication caused by complete aorto-iliac occlusion (rather than stenosis) with critical limb ischaemia who need revascularisation, who should be offered angioplasty or bypass surgery, taking into account factors including: comorbidities pattern of disease availability of a vein for grafting patient preference being considered for primary stent placement, for treating people with critical limb ischaemia caused by complete aorto-iliac occlusion (rather than stenosis).
[Adapted from NICE clinical guideline 147, recommendations 1.5.3, 1.5.5, 1.6.2 and 1.6.4]
Peripheral arterial disease (QS52) Quality statement 5: Angioplasty for intermittent claudication Quality statement 5: Angioplasty for intermittent claudication
Quality statement
People with intermittent claudication are offered angioplasty only when imaging has confirmed it is appropriate, after advice on the benefits of modifying risk factors has been given, and after a supervised exercise programme has not improved symptoms.
Rationale
Angioplasty can be used to treat intermittent claudication, but it is an invasive procedure and should only be used after non-invasive options (including reinforcement of the importance of lifestyle changes and participation in supervised exercise programmes) have not improved symptoms, and imaging has confirmed that angioplasty is suitable. Greater use of non-invasive treatments may reduce the need for angioplasty and improve overall outcomes for peripheral arterial disease (PAD).
Quality measures
Evidence of local arrangements to ensure that people with intermittent claudication are offered angioplasty only when imaging has confirmed it is appropriate, advice on the benefits of modifying risk factors has been given and a supervised exercise programme has not improved symptoms.
Data sour
Process Process
Proportion of people with intermittent claudication receiving angioplasty who have had imaging to confirm angioplasty is appropriate, received advice on the benefits of modifying risk factors and undergone a supervised exercise programme that did not improve symptoms.
Numerator -the number of people in the denominator who have had imaging to confirm angioplasty is appropriate, received advice on the benefits of modifying risk factors and undergone supervised exercise programme that did not improve symptoms.
Denominator -the number of people with intermittent claudication who receive angioplasty. 
What the quality statement means for service providers, healthcare practitioners and commissioners
Service pro Service providers viders ensure that supervised exercise programmes are adequately available and have local protocols in place to ensure healthcare practitioners only offer angioplasty to people with intermittent claudication when imaging has confirmed it is appropriate, advice on the benefits of modifying risk factors has been given and a supervised exercise programme has not improved symptoms.
Healthcare pr Healthcare practitioners actitioners ensure that they offer angioplasty to people with intermittent claudication only when imaging has confirmed it is appropriate, advice on the benefits of modifying risk factors has been given and a supervised exercise programme has not improved symptoms.
Commissioners Commissioners ensure that they commission services in which people with intermittent claudication are only offered angioplasty when imaging has confirmed it is appropriate, advice on the benefits of modifying risk factors has been given and a supervised exercise programme has not improved symptoms.
What the quality statement means for patients, service users and carers
P People who ha eople who hav ve pain when walking because of poor circulation e pain when walking because of poor circulation are offered angioplasty (a procedure in which a small balloon is inserted into the narrowed artery and inflated to widen the artery) only when an imaging test has confirmed that angioplasty is suitable, and advice on the risk factors of peripheral arterial disease and a supervised exercise programme have not improved symptoms.
Source guidance
Lower limb peripheral arterial disease (NICE clinical guideline 147), recommendation 1.5.3. Using the quality standard Using the quality standard
Definitions of terms used in this quality statement
Quality measures
The quality measures accompanying the quality statements aim to improve the structure, process and outcomes of care in areas identified as needing quality improvement. They are not a new set of targets or mandatory indicators for performance management.
We have indicated if current national indicators exist that could be used to measure the quality statements. These include indicators developed by the Health and Social Care Information Centre through its Indicators for Quality Improvement Programme. If there is no national indicator that could be used to measure a quality statement, the quality measure should form the basis for audit criteria developed and used locally.
See NICE's What makes up a NICE quality standard? for further information, including advice on using quality measures.
Levels of achievement
Expected levels of achievement for quality measures are not specified. Quality standards are intended to drive up the quality of care, and so achievement levels of 100% should be aspired to (or 0% if the quality statement states that something should not be done). However, NICE recognises that this may not always be appropriate in practice, taking account of safety, choice and professional judgement, and therefore desired levels of achievement should be defined locally.
Using other national guidance and policy documents
Other national guidance and current policy documents have been referenced during the development of this quality standard. It is important that the quality standard is considered by commissioners, providers, health, public health and social care practitioners, patients, service users and carers alongside the documents listed in Development sources.
Information for commissioners
NICE has produced support for commissioning that considers the commissioning implications and potential resource impact of this quality standard. This is available on the NICE website. Commissioners and providers should aim to achieve the quality standard in their local context, in light of their duties to have due regard to the need to eliminate unlawful discrimination, advance equality of opportunity and foster good relations. Nothing in this quality standard should be interpreted in a way that would be inconsistent with compliance with those duties.
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De Dev velopment sources elopment sources
Further explanation of the methodology used can be found in the quality standards Process guide on the NICE website.
Evidence sources
The documents below contain recommendations from NICE guidance or other NICE-accredited recommendations that were used by the Quality Standards Advisory Committee to develop the quality standard statements and measures.
Lower limb peripheral arterial disease. NICE clinical guideline 147 (2012).
Policy context
It is important that the quality standard is considered alongside current policy documents, Definitions and data sources for the quality measures Quality and Outcomes Framework (2013/14 
